Skip to main content
Screener/Healthcare/Biotechnology

LCTX — Lineage Cell Therapeutics, Inc.

AMEX
$1.10-0.03 (-2.21%)
Micro CapPenny StockUnder $5HealthcareHigh DividendDividend Stock
$0.95
$2.09
$1.08
$1.14
EPS (TTM)$-0.28
P/E Ratio-5.65
Dividend Yield7.41%
Market Cap$269.2M
Volume661K
Prev Close$1.13
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$1.7M-$4.8M$-0.0289.1%-279.0%
Q4 '25$6.6M$851K$0.0088.4%12.9%
Q3 '25$3.7M-$29.8M$-0.1399.9%-809.0%
Q2 '25$2.8M-$30.5M$-0.1398.6%-1101.8%
Q1 '25$1.5M-$4.1M$-0.0297.6%-275.6%
Q4 '24$2.9M-$3.3M$-0.0294.6%-114.1%
Q3 '24$3.8M-$3.0M$-0.0299.0%-80.3%
Q2 '24$1.4M-$5.8M$-0.0396.9%-409.1%
Get Your Daily Market Recap